Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03854903 |
|---|---|
| Brief Title: | WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor |
| First Submitted : | February 21, 2019 |
| First Submitted that Met QC Criteria : | February 25, 2019 |
| First Posted : | February 26, 2019 |
| Last Update Submitted that Met QC Criteria : | April 1, 2020 |
| Last Update Posted : | April 2, 2020 |